154 related articles for article (PubMed ID: 31121994)
41. Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study.
Korda RJ; Soga K; Joshy G; Calabria B; Attia J; Wong D; Banks E
Int J Equity Health; 2016 Nov; 15(1):189. PubMed ID: 27871298
[TBL] [Abstract][Full Text] [Related]
42. Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study.
Seong JM; Choi NK; Shin JY; Chang Y; Kim YJ; Lee J; Kim JY; Park BJ
PLoS One; 2015; 10(5):e0124287. PubMed ID: 25992614
[TBL] [Abstract][Full Text] [Related]
43. Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
.
Eisen C; Lulic Z; Palacios-Moreno JM; Adalig B; Hennig M; Cortes V; Gilg F; Kostev K
Int J Clin Pharmacol Ther; 2020 Jan; 58(1):37-49. PubMed ID: 31670653
[TBL] [Abstract][Full Text] [Related]
44. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
Shah M; Butler M; Bramley T; Curtice TG; Fine S
Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
[TBL] [Abstract][Full Text] [Related]
45. The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study.
Johnstone J; Lusty A; Tohidi M; Whitehead M; Tranmer J; Nickel JC; Siemens DR
Can Urol Assoc J; 2021 Aug; 15(8):240-246. PubMed ID: 34895443
[TBL] [Abstract][Full Text] [Related]
46. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
Ørsted DD; Bojesen SE; Nielsen SF; Nordestgaard BG
Eur Urol; 2011 Oct; 60(4):691-8. PubMed ID: 21705134
[TBL] [Abstract][Full Text] [Related]
47. Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.
Kukko V; Kaipia A; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):373-378. PubMed ID: 29273728
[TBL] [Abstract][Full Text] [Related]
48. Long-Term Cumulative Exposure to High γ-Glutamyl Transferase Levels and the Risk of Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
Baek HS; Kim B; Lee SH; Lim DJ; Kwon HS; Chang SA; Han K; Yun JS
Endocrinol Metab (Seoul); 2023 Dec; 38(6):770-781. PubMed ID: 37926990
[TBL] [Abstract][Full Text] [Related]
49. 5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer.
Robinson D; Garmo H; Holmberg L; Stattin P
Cancer Causes Control; 2015 Sep; 26(9):1289-97. PubMed ID: 26109464
[TBL] [Abstract][Full Text] [Related]
50. Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?
Bruha M; Welliver C
Curr Urol Rep; 2017 Oct; 18(10):75. PubMed ID: 28766115
[TBL] [Abstract][Full Text] [Related]
51. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
52. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
[TBL] [Abstract][Full Text] [Related]
53. Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink.
Hagberg KW; Divan HA; Persson R; Nickel JC; Jick SS
BMJ; 2016 Sep; 354():i4823. PubMed ID: 27659058
[TBL] [Abstract][Full Text] [Related]
54. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
[TBL] [Abstract][Full Text] [Related]
55. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
[TBL] [Abstract][Full Text] [Related]
56. Association of smoking cessation after atrial fibrillation diagnosis on the risk of cardiovascular disease: a cohort study of South Korean men.
Choi S; Chang J; Kim K; Kim SM; Koo HY; Cho MH; Cho IY; Lee H; Son JS; Park SM; Lee K
BMC Public Health; 2020 Feb; 20(1):168. PubMed ID: 32013964
[TBL] [Abstract][Full Text] [Related]
57. Positive Association of Male Overactive Bladder Symptoms and Androgen Deprivation: A Nationwide Population-based Cohort Study.
Li JR; Wang SS; Lin CH; DE Groat WC; Cheng CL
Anticancer Res; 2019 Jan; 39(1):305-311. PubMed ID: 30591473
[TBL] [Abstract][Full Text] [Related]
58. Medical management of benign prostatic hyperplasia: Results from a population-based study.
Bishr M; Boehm K; Trudeau V; Tian Z; Dell'Oglio P; Schiffmann J; Jeldres C; Sun M; Shariat SF; Graefen M; Saad F; Karakiewicz PI
Can Urol Assoc J; 2016; 10(1-2):55-9. PubMed ID: 26977208
[TBL] [Abstract][Full Text] [Related]
59. [Pharmacological treatment of benign prostatic hyperplasia].
Oelke M; Martinelli E
Urologe A; 2016 Jan; 55(1):81-94; quiz 95-6. PubMed ID: 26676726
[TBL] [Abstract][Full Text] [Related]
60. Association between urban green space and the risk of cardiovascular disease: A longitudinal study in seven Korean metropolitan areas.
Seo S; Choi S; Kim K; Kim SM; Park SM
Environ Int; 2019 Apr; 125():51-57. PubMed ID: 30703611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
